Paul B Manning Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Paul B Manning.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Paul B Manning. Paul B Manning is Director in AveXis, Inc. ($AVXS) and Director in Verrica Pharmaceuticals Inc. ($VRCA) and Director in Dova Pharmaceuticals, Inc. ($DOVA) and Director in Taysha Gene Therapies, Inc. ($TSHA) and Director in Liquidia Corp ($LQDA).
Latest Insider Trading Transactions of Paul B Manning
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AVXS, DOVA, LQDA, TSHA, VRCA
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 17 2021 | TSHA | Taysha Gene Therap ... | Manning Paul B | Director | Buy | P | 20.98 | 12,000 | 251,760 | 12,000 | 0 to 12 K |
Apr 15 2021 | LQDA | Liquidia Corp | Manning Paul B | Director | Buy | P | 2.52 | 198,413 | 500,001 | 737,646 | 539.2 K to 737.6 K (+36.80 %) |
Mar 29 2021 | VRCA | Verrica Pharmaceut ... | Manning Paul B | Director | Buy | P | 14.75 | 739,830 | 10,912,493 | 739,830 | 0 to 739.8 K |
Mar 26 2021 | LQDA | Liquidia Corp | Manning Paul B | Director | Option Exercise | A | 2.51 | 21,385 | 53,676 | 21,385 | |
Nov 19 2020 | LQDA | Liquidia Corp | Manning Paul B | Director | Option Exercise | A | 3.38 | 30,000 | 101,400 | 30,000 | |
Sep 30 2020 | TSHA | Taysha Gene Therap ... | Manning Paul B | Director | Option Exercise | C | 0.00 | 10,963 | 0 | 0 | |
Sep 30 2020 | TSHA | Taysha Gene Therap ... | Manning Paul B | Director | Option Exercise | C | 0.00 | 1,843,193 | 0 | 0 | |
Sep 30 2020 | TSHA | Taysha Gene Therap ... | Manning Paul B | Director | Option Exercise | C | 0.00 | 3,006,155 | 0 | 0 | |
Sep 30 2020 | TSHA | Taysha Gene Therap ... | Manning Paul B | Director | Buy | C | 0.00 | 11,944 | 0 | 2,020,102 | 2 M to 2 M (+0.59 %) |
Sep 30 2020 | TSHA | Taysha Gene Therap ... | Manning Paul B | Director | Buy | C | 0.00 | 2,008,158 | 0 | 2,008,158 | 0 to 2 M |
Sep 30 2020 | TSHA | Taysha Gene Therap ... | Manning Paul B | Director | Buy | C | 0.00 | 3,275,205 | 0 | 3,275,205 | 0 to 3.3 M |
Sep 25 2020 | TSHA | Taysha Gene Therap ... | Manning Paul B | Director | Option Exercise | A | 20.00 | 31,000 | 620,000 | 31,000 | |
Aug 21 2020 | VRCA | Verrica Pharmaceut ... | Manning Paul B | Director | Buy | P | 9.09 | 20,000 | 181,800 | 8,099,394 | 8.1 M to 8.1 M (+0.25 %) |
Aug 19 2020 | VRCA | Verrica Pharmaceut ... | Manning Paul B | Director | Buy | P | 8.55 | 10,000 | 85,500 | 1,481,719 | 1.5 M to 1.5 M (+0.68 %) |
Aug 18 2020 | VRCA | Verrica Pharmaceut ... | Manning Paul B | Director | Buy | P | 6.92 | 6,000 | 41,520 | 1,471,719 | 1.5 M to 1.5 M (+0.41 %) |
Aug 17 2020 | VRCA | Verrica Pharmaceut ... | Manning Paul B | Director | Buy | P | 6.51 | 50,000 | 325,500 | 1,465,719 | 1.4 M to 1.5 M (+3.53 %) |
Aug 17 2020 | VRCA | Verrica Pharmaceut ... | Manning Paul B | Director | Buy | P | 6.41 | 108,500 | 695,485 | 1,415,719 | 1.3 M to 1.4 M (+8.30 %) |
Nov 12 2019 | DOVA | Dova Pharmaceutica ... | Manning Paul B | Director | Sell | U | 27.50 | 1,783,226 | 49,038,715 | 0 | 1.8 M to 0 (-100.00 %) |
Nov 12 2019 | DOVA | Dova Pharmaceutica ... | Manning Paul B | Director | Sell | U | 27.50 | 12,979,016 | 356,922,940 | 0 | 13 M to 0 (-100.00 %) |
Oct 10 2019 | VRCA | Verrica Pharmaceut ... | Manning Paul B | Director | Buy | P | 15.05 | 6,900 | 103,845 | 8,079,394 | 8.1 M to 8.1 M (+0.09 %) |
Oct 10 2019 | VRCA | Verrica Pharmaceut ... | Manning Paul B | Director | Buy | P | 14.06 | 8,778 | 123,419 | 8,072,494 | 8.1 M to 8.1 M (+0.11 %) |
Oct 10 2019 | VRCA | Verrica Pharmaceut ... | Manning Paul B | Director | Buy | P | 14.02 | 5,208 | 73,016 | 8,063,716 | 8.1 M to 8.1 M (+0.06 %) |
Aug 12 2019 | DOVA | Dova Pharmaceutica ... | Manning Paul B | Director | Buy | P | 15.87 | 28,062 | 445,344 | 12,979,016 | 13 M to 13 M (+0.22 %) |
Mar 08 2019 | DOVA | Dova Pharmaceutica ... | Manning Paul B | Director | Buy | P | 7.48 | 68,000 | 508,640 | 12,950,954 | 12.9 M to 13 M (+0.53 %) |
Jan 07 2019 | VRCA | Verrica Pharmaceut ... | Manning Paul B | Director | Buy | P | 11.99 | 911 | 10,923 | 1,307,219 | 1.3 M to 1.3 M (+0.07 %) |
Jan 07 2019 | VRCA | Verrica Pharmaceut ... | Manning Paul B | Director | Buy | P | 11.99 | 911 | 10,923 | 1,307,219 | 1.3 M to 1.3 M (+0.07 %) |
Jan 07 2019 | VRCA | Verrica Pharmaceut ... | Manning Paul B | Director | Buy | P | 11.55 | 6,706 | 77,454 | 1,306,308 | 1.3 M to 1.3 M (+0.52 %) |
Jan 07 2019 | VRCA | Verrica Pharmaceut ... | Manning Paul B | Director | Buy | P | 11.55 | 6,706 | 77,454 | 1,306,308 | 1.3 M to 1.3 M (+0.52 %) |
Jan 07 2019 | VRCA | Verrica Pharmaceut ... | Manning Paul B | Director | Buy | P | 10.41 | 4,258 | 44,326 | 1,299,602 | 1.3 M to 1.3 M (+0.33 %) |
Jan 07 2019 | VRCA | Verrica Pharmaceut ... | Manning Paul B | Director | Buy | P | 10.41 | 4,258 | 44,326 | 1,299,602 | 1.3 M to 1.3 M (+0.33 %) |
Jan 07 2019 | VRCA | Verrica Pharmaceut ... | Manning Paul B | Director | Buy | P | 11.99 | 2,734 | 32,781 | 8,058,508 | 8.1 M to 8.1 M (+0.03 %) |
Jan 07 2019 | VRCA | Verrica Pharmaceut ... | Manning Paul B | Director | Buy | P | 11.99 | 2,734 | 32,781 | 8,058,508 | 8.1 M to 8.1 M (+0.03 %) |
Jan 07 2019 | VRCA | Verrica Pharmaceut ... | Manning Paul B | Director | Buy | P | 11.55 | 20,116 | 232,340 | 8,055,774 | 8 M to 8.1 M (+0.25 %) |
Jan 07 2019 | VRCA | Verrica Pharmaceut ... | Manning Paul B | Director | Buy | P | 11.55 | 20,116 | 232,340 | 8,055,774 | 8 M to 8.1 M (+0.25 %) |
Jan 07 2019 | VRCA | Verrica Pharmaceut ... | Manning Paul B | Director | Buy | P | 10.41 | 12,775 | 132,988 | 8,035,658 | 8 M to 8 M (+0.16 %) |
Jan 07 2019 | VRCA | Verrica Pharmaceut ... | Manning Paul B | Director | Buy | P | 10.41 | 12,775 | 132,988 | 8,035,658 | 8 M to 8 M (+0.16 %) |
Dec 21 2018 | DOVA | Dova Pharmaceutica ... | Manning Paul B | Director | Buy | P | 7.10 | 6,834 | 48,521 | 12,882,954 | 12.9 M to 12.9 M (+0.05 %) |
Dec 21 2018 | DOVA | Dova Pharmaceutica ... | Manning Paul B | Director | Buy | P | 6.44 | 121,666 | 783,529 | 12,876,120 | 12.8 M to 12.9 M (+0.95 %) |
Dec 20 2018 | DOVA | Dova Pharmaceutica ... | Manning Paul B | Director | Buy | P | 6.17 | 266,631 | 1,645,113 | 12,754,454 | 12.5 M to 12.8 M (+2.14 %) |
Aug 15 2018 | VRCA | Verrica Pharmaceut ... | Manning Paul B | Director | Buy | P | 15.00 | 100,000 | 1,500,000 | 1,260,244 | 1.2 M to 1.3 M (+8.62 %) |
Aug 15 2018 | VRCA | Verrica Pharmaceut ... | Manning Paul B | Director | Buy | P | 15.00 | 200,000 | 3,000,000 | 7,987,783 | 7.8 M to 8 M (+2.57 %) |
Aug 14 2018 | VRCA | Verrica Pharmaceut ... | Manning Paul B | Director | Buy | P | 15.08 | 33,000 | 497,640 | 7,787,783 | 7.8 M to 7.8 M (+0.43 %) |
Jun 19 2018 | VRCA | Verrica Pharmaceut ... | Manning Paul B | Director | Option Exercise | C | 0.00 | 256,634 | 0 | 0 | |
Jun 19 2018 | VRCA | Verrica Pharmaceut ... | Manning Paul B | Director | Option Exercise | C | 0.00 | 1,132,900 | 0 | 0 | |
Jun 19 2018 | VRCA | Verrica Pharmaceut ... | Manning Paul B | Director | Option Exercise | C | 0.00 | 7,754,783 | 0 | 0 | |
Jun 19 2018 | VRCA | Verrica Pharmaceut ... | Manning Paul B | Director | Buy | C | 0.00 | 256,634 | 0 | 256,634 | 0 to 256.6 K |
Jun 19 2018 | VRCA | Verrica Pharmaceut ... | Manning Paul B | Director | Buy | C | 0.00 | 1,132,900 | 0 | 1,160,244 | 27.3 K to 1.2 M (+4,143.14 %) |
Jun 19 2018 | VRCA | Verrica Pharmaceut ... | Manning Paul B | Director | Buy | C | 0.00 | 7,754,783 | 0 | 7,754,783 | 0 to 7.8 M |
Jun 08 2018 | DOVA | Dova Pharmaceutica ... | Manning Paul B | Director | Buy | P | 28.03 | 3,400 | 95,302 | 12,487,823 | 12.5 M to 12.5 M (+0.03 %) |
Jun 08 2018 | DOVA | Dova Pharmaceutica ... | Manning Paul B | Director | Buy | P | 27.52 | 6,600 | 181,632 | 12,484,423 | 12.5 M to 12.5 M (+0.05 %) |
Jun 08 2018 | DOVA | Dova Pharmaceutica ... | Manning Paul B | Director | Buy | P | 28.85 | 17,000 | 490,450 | 12,477,823 | 12.5 M to 12.5 M (+0.14 %) |
Jun 06 2018 | DOVA | Dova Pharmaceutica ... | Manning Paul B | Director | Buy | P | 26.93 | 53,020 | 1,427,829 | 12,460,823 | 12.4 M to 12.5 M (+0.43 %) |
Jun 06 2018 | DOVA | Dova Pharmaceutica ... | Manning Paul B | Director | Buy | P | 26.04 | 46,980 | 1,223,359 | 12,407,803 | 12.4 M to 12.4 M (+0.38 %) |
Jun 06 2018 | DOVA | Dova Pharmaceutica ... | Manning Paul B | Director | Buy | P | 24.75 | 11,800 | 292,050 | 12,360,823 | 12.3 M to 12.4 M (+0.10 %) |
Jun 06 2018 | DOVA | Dova Pharmaceutica ... | Manning Paul B | Director | Buy | P | 24.02 | 8,200 | 196,964 | 12,349,023 | 12.3 M to 12.3 M (+0.07 %) |
May 15 2018 | AVXS | AveXis, Inc. | Manning Paul B | Director | Option Exercise | D | 2.57 | 103,478 | 265,938 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | Manning Paul B | Director | Option Exercise | D | 2.57 | 137,154 | 352,486 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | Manning Paul B | Director | Option Exercise | D | 133.80 | 2,905 | 388,689 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | Manning Paul B | Director | Option Exercise | D | 69.25 | 2,454 | 169,940 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | Manning Paul B | Director | Option Exercise | D | 20.00 | 26,496 | 529,920 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | Manning Paul B | Director | Sell | D | 0.00 | 25,293 | 0 | 0 | 25.3 K to 0 (-100.00 %) |
May 15 2018 | AVXS | AveXis, Inc. | Manning Paul B | Director | Sell | D | 0.00 | 1,201,160 | 0 | 0 | 1.2 M to 0 (-100.00 %) |
May 15 2018 | AVXS | AveXis, Inc. | Manning Paul B | Director | Sell | D | 0.00 | 228,752 | 0 | 0 | 228.8 K to 0 (-100.00 %) |
Mar 30 2018 | AVXS | AveXis, Inc. | Manning Paul B | Director | Option Exercise | A | 133.80 | 2,905 | 388,689 | 2,905 | |
Mar 30 2018 | AVXS | AveXis, Inc. | Manning Paul B | Director | Grant | A | 0.00 | 1,106 | 0 | 228,752 | 227.6 K to 228.8 K (+0.49 %) |
Nov 13 2017 | DOVA | Dova Pharmaceutica ... | Manning Paul B | Director | Buy | J | 0.00 | 12,214,953 | 0 | 12,340,823 | 125.9 K to 12.3 M (+9,704.42 %) |
Nov 13 2017 | DOVA | Dova Pharmaceutica ... | Manning Paul B | Director | Sell | J | 0.00 | 12,214,953 | 0 | 0 | 12.2 M to 0 (-100.00 %) |
Aug 17 2017 | DOVA | Dova Pharmaceutica ... | Manning Paul B | Director | Buy | P | 26.81 | 100 | 2,681 | 125,870 | 125.8 K to 125.9 K (+0.08 %) |
Aug 17 2017 | DOVA | Dova Pharmaceutica ... | Manning Paul B | Director | Buy | P | 25.62 | 1,379 | 35,330 | 125,770 | 124.4 K to 125.8 K (+1.11 %) |
Aug 17 2017 | DOVA | Dova Pharmaceutica ... | Manning Paul B | Director | Buy | P | 24.87 | 3,521 | 87,567 | 124,391 | 120.9 K to 124.4 K (+2.91 %) |
Aug 17 2017 | DOVA | Dova Pharmaceutica ... | Manning Paul B | Director | Buy | P | 22.39 | 7,870 | 176,209 | 120,870 | 113 K to 120.9 K (+6.96 %) |
Aug 17 2017 | DOVA | Dova Pharmaceutica ... | Manning Paul B | Director | Buy | P | 21.16 | 13,000 | 275,080 | 113,000 | 100 K to 113 K (+13.00 %) |
Jul 07 2017 | DOVA | Dova Pharmaceutica ... | Manning Paul B | Director | Buy | P | 17.00 | 50,000 | 850,000 | 1,783,226 | 1.7 M to 1.8 M (+2.88 %) |
Jul 07 2017 | DOVA | Dova Pharmaceutica ... | Manning Paul B | Director | Buy | P | 17.00 | 100,000 | 1,700,000 | 100,000 | 0 to 100 K |
Jun 01 2017 | AVXS | AveXis, Inc. | Manning Paul B | Director | Option Exercise | A | 69.25 | 2,454 | 169,940 | 2,454 | |
Sep 15 2016 | AVXS | AveXis, Inc. | Manning Paul B | Director | Sell | S | 34.50 | 289,855 | 9,999,998 | 1,201,160 | 1.5 M to 1.2 M (-19.44 %) |
Feb 19 2016 | AVXS | AveXis, Inc. | Manning Paul B | Director | Option Exercise | C | 2.57 | 137,154 | 352,486 | 137,154 | |
Feb 19 2016 | AVXS | AveXis, Inc. | Manning Paul B | Director | Option Exercise | C | 2.57 | 130,623 | 335,701 | 130,623 | |
Feb 19 2016 | AVXS | AveXis, Inc. | Manning Paul B | Director | Option Exercise | C | 2.57 | 137,154 | 352,486 | 0 | |
Feb 19 2016 | AVXS | AveXis, Inc. | Manning Paul B | Director | Option Exercise | C | 2.57 | 130,623 | 335,701 | 0 | |
Feb 19 2016 | AVXS | AveXis, Inc. | Manning Paul B | Director | Option Exercise | C | 0.00 | 1,659,237 | 0 | 0 | |
Feb 19 2016 | AVXS | AveXis, Inc. | Manning Paul B | Director | Option Exercise | C | 0.00 | 941 | 0 | 0 | |
Feb 19 2016 | AVXS | AveXis, Inc. | Manning Paul B | Director | Option Exercise | C | 0.00 | 8,469 | 0 | 0 | |
Feb 19 2016 | AVXS | AveXis, Inc. | Manning Paul B | Director | Buy | C | 0.00 | 1,659,237 | 0 | 1,659,237 | 0 to 1.7 M |
Feb 19 2016 | AVXS | AveXis, Inc. | Manning Paul B | Director | Buy | C | 0.00 | 941 | 0 | 25,293 | 24.4 K to 25.3 K (+3.86 %) |
Feb 19 2016 | AVXS | AveXis, Inc. | Manning Paul B | Director | Buy | C | 0.00 | 8,469 | 0 | 227,646 | 219.2 K to 227.6 K (+3.86 %) |
Feb 12 2016 | AVXS | AveXis, Inc. | Manning Paul B | Director | Option Exercise | A | 20.00 | 8,385 | 167,700 | 8,385 | |
Feb 12 2016 | AVXS | AveXis, Inc. | Manning Paul B | Director | Option Exercise | A | 20.00 | 18,111 | 362,220 | 18,111 |
Page: 1